IN2013MU01250A - - Google Patents
Info
- Publication number
- IN2013MU01250A IN2013MU01250A IN1250MU2013A IN2013MU01250A IN 2013MU01250 A IN2013MU01250 A IN 2013MU01250A IN 1250MU2013 A IN1250MU2013 A IN 1250MU2013A IN 2013MU01250 A IN2013MU01250 A IN 2013MU01250A
- Authority
- IN
- India
- Prior art keywords
- methylphenidate
- salts
- release
- composition
- pharmaceutical compositions
- Prior art date
Links
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical group C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 abstract 3
- 229960001344 methylphenidate Drugs 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 238000013265 extended release Methods 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1250MU2013 IN2013MU01250A (OSRAM) | 2013-03-29 | 2014-03-24 | |
| PCT/IB2014/060084 WO2014174388A1 (en) | 2013-03-29 | 2014-03-24 | Modified release pharmaceutical compositions of methylphenidate or salts thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1250MU2013 IN2013MU01250A (OSRAM) | 2013-03-29 | 2014-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU01250A true IN2013MU01250A (OSRAM) | 2015-04-17 |
Family
ID=54395650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1250MU2013 IN2013MU01250A (OSRAM) | 2013-03-29 | 2014-03-24 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU01250A (OSRAM) |
-
2014
- 2014-03-24 IN IN1250MU2013 patent/IN2013MU01250A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019502355A1 (en) | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b | |
| MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
| IN2015DN01156A (OSRAM) | ||
| MX2020010535A (es) | Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide. | |
| UA117261C2 (uk) | Похідні карбоксаміду та їх застосування як медикаментів для лікування гепатиту b | |
| MX2013011691A (es) | Inhibidores de la replicacion viral, su proceso de preparacion y sus usos terapeuticos. | |
| PH12015500724A1 (en) | 1, 2, 4-triazine derivatives for the treatment of viral infections | |
| MX342119B (es) | 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
| MX367926B (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
| MX2015005733A (es) | Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad. | |
| MX2015005111A (es) | Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada. | |
| IN2014DN09437A (OSRAM) | ||
| GB201115977D0 (en) | Neurodevelopmental disorders | |
| MX2013002295A (es) | 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
| IN2013MU01249A (OSRAM) | ||
| IN2013MU01248A (OSRAM) | ||
| IN2013MU01247A (OSRAM) | ||
| IN2013MU01246A (OSRAM) | ||
| IN2013MU01244A (OSRAM) | ||
| IN2013MU01245A (OSRAM) | ||
| IN2013MU01250A (OSRAM) | ||
| IN2013MU01242A (OSRAM) | ||
| IN2013MU01241A (OSRAM) | ||
| IN2013MU01240A (OSRAM) | ||
| IN2013MU01243A (OSRAM) |